» Authors » Rabab M Aly

Rabab M Aly

Explore the profile of Rabab M Aly including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 29
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Aly R, Taalab M, Abdsalam E, Elyamany O, Hasan O
Oncol Lett . 2016 Mar; 11(3):1917-1922. PMID: 26998100
The LIM domain only protein 2 (LMO2) is a key regulator of hematopoietic stem cell development. Expression of LMO2 has been evaluated in B-cell lymphoma, T-cell acute lymphoblastic leukemia and...
2.
Aly R, Taalab M, Abdsalam E
Am J Med Sci . 2015 Oct; 350(5):369-73. PMID: 26517501
Background: Deregulation of secreted frizzled-related protein 2 (sFRP2) has been found in many types of cancer. However, the pattern of sFRP2 expression in acute myeloid leukemia (AML) is still unclear....
3.
Aly R, Yousef A
Turk J Haematol . 2015 Mar; 32(1):15-20. PMID: 25805670
Objective: Lymphoid enhancer-binding factor-1 (LEF-1) is a key transcription factor of wingless-type (Wnt) signaling in various tumors and it is associated with a number of malignant diseases such as leukemia....
4.
Aly R, Ghazy H
Blood Cells Mol Dis . 2014 Aug; 53(4):185-8. PMID: 25088035
Background: GRAF is a recognized tumor suppressor gene that was found inactivated in AML. However, the prognostic role of a GRAF transcript has not been studied in patients with AML....
5.
Aly R, Taalab M, Ghazy H
Int J Clin Exp Pathol . 2014 Jun; 7(5):2571-8. PMID: 24966971
Methylenetetrahydrofolate reductase (MTHFR) is a key enzyme regulating the intracellular folate metabolism which plays an important role in carcinogenesis through DNA methylation. We aimed to evaluate the association between MTHFR...
6.
Aly R, Taalab M, Ghazy H
Leuk Lymphoma . 2014 Apr; 56(1):151-6. PMID: 24689757
The aim of this study was to analyze the association of the rs10519612 and rs17007695 polymorphisms with the risk of acute lymphoblastic leukemia (ALL) and also to evaluate their impact...
7.
Aly R, El-sharnoby M, Hagag A
Mediterr J Hematol Infect Dis . 2012 Jan; 3(1):e2011055. PMID: 22220252
Background: NRAS mutations are the most commonly detected molecular abnormalities in hematologic malignancies, especially in those of myeloid origin. Objective: We aimed to determine the frequency of NRAS (NRAS(mutant)) mutation;...
8.
Elghannam D, Aly R, Goda E, Eltoraby E, Farag R
Asian J Transfus Sci . 2009 Dec; 3(1):14-7. PMID: 20041091
Background: In spite of the progress made in the prevention of transfusion transmitted infections over the last few years, transmission of HBV infection through transfusion of HBsAg negative blood has...